TSND, CA88105E1088

TerrAscend closes Aunt Mary's deal while TerrAscend stock trades at EUR 0.44

Published on 10/15/2026 at 12:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aunt Mary's gives TerrAscend a fifth New Jersey store. TerrAscend stock trades at EUR 0.44 on October 15, 2026 with a CAD 207.1 million TSX market cap.

Retail expansion and quarterly figures

  • On September 16, 2026, TerrAscend closed a USD 9 million Aunt Mary's transaction.
  • Second-quarter 2026 revenue reached USD 67.1 million, with a 54.0 percent gross margin.
  • TerrAscend stock was trading at EUR 0.44 at 12:41 p.m. CEST at Lang & Schwarz on October 15, 2026.
TSND, CA88105E1088, Illustration mit AI erstellt.
TSND, CA88105E1088, Illustration mit AI erstellt.

TerrAscend (ISIN CA88105E1088) trades at EUR 0.44 at Lang & Schwarz on October 15, 2026 at 12:41 p.m. CEST, while its latest expansion adds a fifth New Jersey dispensary. The company closed the Aunt Mary's transaction on September 16, 2026, according to TerrAscend.

Three expansion milestones

In June 2026, TerrAscend agreed to total consideration of USD 9 million for the Aunt Mary's transaction, including a USD 3 million five-year convertible debenture carrying 6.0 percent interest and USD 6 million payable in cash upon exercise of an option. The September 16, 2026 closing gave the company its fifth New Jersey retail location and a path to a consolidated footprint of 21 dispensaries across five U.S. states and Canada, the company release said.

On August 6, 2026, TerrAscend reported second-quarter 2026 revenue of USD 67.1 million, up 3.3 percent year over year, while gross margin reached 54.0 percent. Zacks reported that adjusted EBITDA margin was 26.3 percent and free cash flow was USD 5.7 million in the quarter.

What does the deal add?

Aunt Mary's generates more than USD 10 million in annualized revenue, giving the acquisition a measurable operating footprint beyond its store count. The company said the location should be immediately accretive to EBITDA and free cash flow, although full consolidation depends on exercising the option and satisfying additional conditions.

Next reporting date

ToAlpha lists November 12, 2026 as TerrAscend's next reporting date. That date would put third-quarter 2026 results next in the company calendar after the second-quarter figures reported on August 6, 2026.

Stock price and company scale

TerrAscend's market value was CAD 207.1 million on October 14, 2026, with a TSX 52-week range of CAD 0.53 to CAD 2.00. The current euro quotation is therefore best read alongside the company's operating progress and its still developing New Jersey retail base.

TerrAscend was trading at EUR 0.44 at Lang & Schwarz on October 15, 2026 at 12:41 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of TerrAscend stock.

TerrAscend stock at a glance

  • Company: TerrAscend Corp.
  • ISIN: CA88105E1088
  • Ticker: TSND
  • Primary exchange: TSX
  • Price Lang & Schwarz (as of October 15, 2026, 12:41 p.m. CEST): EUR 0.44
  • Market capitalization: CAD 207.1 million (as of October 14, 2026)
  • 52-week range: CAD 0.53-2.00 (as of October 14, 2026)
  • Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic

Market context: Market report S&P TSX Composite.

More news and analyses on TerrAscend stock

Disclaimer...

en | CA88105E1088 | TSND | boerse | 70329101 | bgmi